Future of research into rotavirus vaccine. Cost effectiveness of vaccine is being assessed
- PMID: 11154636
- PMCID: PMC1119353
Future of research into rotavirus vaccine. Cost effectiveness of vaccine is being assessed
Comment on
-
The future of research into rotavirus vaccine.BMJ. 2000 Sep 2;321(7260):525-6. doi: 10.1136/bmj.321.7260.525. BMJ. 2000. PMID: 10968800 Free PMC article. No abstract available.
References
-
- Andersson N, Paredes S, Legorreta J, Ledogar RJ. Who pays for measles? The economic arguments for sustained immunization. Health Policy and Planning. 1992;7:352–363.
-
- Miller M, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae conjugate and rotavirus vaccines in national immunization schedules. Health Econ. 2000;9:19–35. - PubMed
-
- Gomez J, Nates S, de-Castagnaro N, Espul C, Borsa A, Glass R. Anticipating rotavirus vaccines: review of epidemiologic studies of rotavirus diarrhoea in Argentina. Rev Panam Salud Publica. 1998;3:69–78. - PubMed
-
- Intussusception among recipients of rotavirus vaccine—United States, 1998-1999. MMWR. 1999;48:577–581. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources